Rekvina Laboratories Statistics
Total Valuation
BOM:526075 has a market cap or net worth of INR 554.68 million. The enterprise value is 569.25 million.
| Market Cap | 554.68M |
| Enterprise Value | 569.25M |
Important Dates
The next estimated earnings date is Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:526075 has 11.12 million shares outstanding.
| Current Share Class | 11.12M |
| Shares Outstanding | 11.12M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.41% |
| Owned by Insiders (%) | 87.36% |
| Owned by Institutions (%) | n/a |
| Float | 274,728 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 28.68 |
| PB Ratio | -45.16 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 29.44 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -254.95% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 19.03% |
| Revenue Per Employee | 3.87M |
| Profits Per Employee | -679,600 |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 2.78 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 41.55 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 48.96 |
| Average Volume (20 Days) | 5,213 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:526075 had revenue of INR 19.34 million and -3.40 million in losses. Loss per share was -0.56.
| Revenue | 19.34M |
| Gross Profit | 963,000 |
| Operating Income | -3.40M |
| Pretax Income | -3.40M |
| Net Income | -3.40M |
| EBITDA | n/a |
| EBIT | -3.40M |
| Loss Per Share | -0.56 |
Balance Sheet
The company has 153,000 in cash and 14.73 million in debt, with a net cash position of -14.57 million or -1.31 per share.
| Cash & Cash Equivalents | 153,000 |
| Total Debt | 14.73M |
| Net Cash | -14.57M |
| Net Cash Per Share | -1.31 |
| Equity (Book Value) | -12.28M |
| Book Value Per Share | -2.03 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | -5.94M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 12.26M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 4.98%, with operating and profit margins of -17.57% and -17.57%.
| Gross Margin | 4.98% |
| Operating Margin | -17.57% |
| Pretax Margin | -17.57% |
| Profit Margin | -17.57% |
| EBITDA Margin | n/a |
| EBIT Margin | -17.57% |
| FCF Margin | n/a |
Dividends & Yields
BOM:526075 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -0.61% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 30, 2014. It was a forward split with a ratio of 2.
| Last Split Date | Apr 30, 2014 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |